The immunomodulatory effects of macrolides—a systematic review of the underlying mechanisms

P Zimmermann, VC Ziesenitz, N Curtis… - Frontiers in …, 2018 - frontiersin.org
Background The mechanisms underlying the non-antimicrobial immunomodulatory
properties of macrolides are not well understood. Objectives To systematically review the …

Mechanisms of action and clinical application of macrolides as immunomodulatory medications

S Kanoh, BK Rubin - Clinical microbiology reviews, 2010 - Am Soc Microbiol
Macrolides have diverse biological activities and an ability to modulate inflammation and
immunity in eukaryotes without affecting homeostatic immunity. These properties have led to …

Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non–cystic fibrosis bronchiectasis: the BAT randomized controlled trial

J Altenburg, CS de Graaff, Y Stienstra, JH Sloos… - Jama, 2013 - jamanetwork.com
Importance Macrolide antibiotics have been shown beneficial in cystic fibrosis (CF) and
diffuse panbronchiolitis, and earlier findings also suggest a benefit in non-CF …

Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial

C Wong, L Jayaram, N Karalus, T Eaton, C Tong… - The Lancet, 2012 - thelancet.com
Background Azithromycin is a macrolide antibiotic with anti-inflammatory and
immunomodulatory properties. We tested the hypothesis that azithromycin would decrease …

Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases

P Zarogoulidis, N Papanas, I Kioumis… - European journal of …, 2012 - Springer
Background Macrolides have long been recognised to exert immunomodulary and anti-
inflammatory actions. They are able to suppress the “cytokine storm” of inflammation and to …

Clarithromycin targets neutrophilic airway inflammation in refractory asthma

JL Simpson, H Powell, MJ Boyle, RJ Scott… - American journal of …, 2008 - atsjournals.org
Rationale: Patients with refractory asthma have persistent symptoms despite maximal
treatment with inhaled corticosteroids and long-acting bronchodilators. The availability of …

[HTML][HTML] Clinical practice guidelines for diagnosis and management of cough—Chinese Thoracic Society (CTS) Asthma Consortium

K Lai, H Shen, X Zhou, Z Qiu, S Cai… - Journal of Thoracic …, 2018 - ncbi.nlm.nih.gov
Cough is the most common symptom in respiratory specialist clinics of tertiary hospitals and
outpatient clinics of primary health care facilities. In China, patients with chronic cough …

Macrolide antibiotics for bronchiectasis

C Kelly, JD Chalmers, I Crossingham… - Cochrane Database …, 2018 - cochranelibrary.com
Background Bronchiectasis is a chronic respiratory disease characterised by abnormal and
irreversible dilatation and distortion of the smaller airways. Bacterial colonisation of the …

Immunomodulatory effects of macrolide antibiotics–part 1: biological mechanisms

J Altenburg, CS De Graaff, TS Van Der Werf… - Respiration, 2010 - karger.com
Macrolide antibiotics are well known for their antibacterial and anti-inflammatory properties.
This article provides an overview of the biological mechanisms through which macrolides …

“A rose is a rose is a rose,” but CVID is not CVID: common variable immune deficiency (CVID), what do we know in 2011?

PFK Yong, JED Thaventhiran, B Grimbacher - Advances in immunology, 2011 - Elsevier
Common variable immune deficiency (CVID) is the commonest symptomatic primary
immunodeficiency and represents a heterogenous collection of disorders resulting mostly in …